Faraha Ahmed

Ms. Faraha Ahmed

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
Javed AhmadJaved Ahmad
Javed Ahmad
HAHassan A. Albarqi
Hassan A. Albarqi
Mohammad Zaki AhmadMohammad Zaki Ahmad
Mohammad Zaki Ahmad
MOMohamed A. A. Orabi
Mohamed A. A. Orabi
Shadab MDShadab MD
Shadab MD
AMAwanish Mishra
Awanish Mishra
Osteoporosis, a chronic bone disorder, is one of the leading causes of fracture and morbidity risk. Numerous medicinally important herbs have been evaluated for their efficacy in improving bone mass density in exhaustive preclinical and limited clinical studies. Nigella sativa L. has been used as local folk medicine, and traditional healers have used it to manage various ailments. Its reported beneficial effects include controlling bone and joint diseases. The present manuscript aimed to provide a sound discussion on the pharmacological evidence of N. sativa and its active constituent, thymoquinone, for its utility in the effective management of osteoporosis. N. sativa is reported to possess anti-IL-1 and anti-TNF-α-mediated anti-inflammatory effects, leading to positive effects on bone turnover markers, such as alkaline phosphatase and tartrate-resistant acid phosphatase. It is reported to stimulate bone regeneration by prompting osteoblast proliferation, ossification, and decreasing osteoclast cells. Thymoquinone from N. sativa has exhibited an antioxidant effect on bone tissue by reducing the FeNTA-induced oxidative stress. The present manuscript highlights phytochemistry, pharmacological effect, and the important mechanistic perspective of N. sativa and its active constituents for the management of osteoporosis. Further, it also provides sound discussion on the utilization of a nanotechnology-mediated drug delivery approach as a promising strategy to improve the therapeutic performance of N. sativa and its active constituent, thymoquinone, in the effective management of osteoporosis.

1 May 2025 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
SSSadat Shafi
Sadat Shafi
FAFaraha Ahmed
Faraha Ahmed
FAFaraha Ahmed
Faraha Ahmed
SASyed Sufiyan Ahmad
Syed Sufiyan Ahmad
SKSana Khan
Sana Khan
ANAbul Kalam Najmi
Abul Kalam Najmi
Considerable advancements have been made in breast cancer therapeutics in the past few decades. However, the advent of chemo-resistance and adverse drug reactions coupled with tumor metastasis and recurrence posed a serious threat to combat this lethal disease. Novel anti-cancer agents, as well as new therapeutic strategies, are needed to complement conventional breast cancer therapies. The quest for developing novel anti-cancer drugs caused an upsurge in exploring and harnessing natural compounds, especially phytochemicals. Various research groups have explored and documented the anti-cancer potential of wide variety of phytochemical groups including flavonoids (curcumin, kaempferol, myricetin, quercetin, naringenin, apigenin, genistein epigallocatechin gallate), stilbenes (resveratrol), carotenoids (crocin, lycopene, lutein), and anthraquinone (Emodin). However, low chemical stability, poor water solubility, and short systemic half-life impede their clinical utility. The implication of nano-technological approaches to decode the pharmacokinetic challenges associated with phytochemical usage, as well as selective drug targeting, have markedly enhanced the pre-clinical anti-cancer activity, thus aiding in their clinical translation. This review documented the recent advances in utilizing phytochemicals for breast cancer prevention and lipidbased nanotechnological approaches for circumventing their pharmacokinetic concerns to enhance their systemic availability, cytotoxicity, and targeted delivery against breast cancer alone as well as in combination with conventional therapeutic agents.

1 January 2026 in Current Drug Therapy
Verified
Journal Article
Closed access
PDF file
FAFaraha Ahmed
Faraha Ahmed
SASyed Sufian Ahmad
Syed Sufian Ahmad
ANAbul Kalam Najmi
Abul Kalam Najmi
MKMohammad Ahmed Khan
Mohammad Ahmed Khan
Understanding the structure, development, and maintenance of bone is crucial to the assessment of bone health and interpretation of clinical outcomes. Bone turnover markers released during bone remodeling have been extensively investigated in osteoporosis studies. These markers include bone formation markers, which are involved in osteogenesis, and bone resorption markers, which break down the bone structure. Although these markers complement bone mineral density results, their clinical use faces challenges because of fluctuations related to factors such as age, gender, and circadian rhythms, as well as analytical variability. Dipeptidyl peptidase-4 (DPP-4) is a ubiquitous exopeptidase that regulates the functions of various proteins. It is present in bound and free form and circulates freely in the extracellular space. It regulates glucose metabolism, cell migration and differentiation, oxidative stress, inflammation, cellular signaling, and the immune system. It also plays an important role in collagen metabolism due to its presence in osteocytes, osteoclasts, and osteoblasts. The substrates of DPP-4, like gastrointestinal peptides, incretins, and neuropeptides, influence bone homeostasis as well via modulation of bone markers. This review explores bone turnover markers in relation to DPP-4 to better understand their role in bone metabolism concerning osteoporosis.

12 June 2025 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
FAFaraha Ahmed
Faraha Ahmed
SASyed Sufian Ahmad
Syed Sufian Ahmad
ANAbul Kalam Najmi
Abul Kalam Najmi
MKMohammad Ahmed Khan
Mohammad Ahmed Khan
Ageing population progressively develops issues with skeletal health. One such major skeletal disorder is osteoporosis, that is sparked with imbalanced bone remodelling and is characterised by weak bones, altered microarchitecture along with increased fragility. These bone alterations commonly lead to vertebral or hip fractures in elderly. The physiological activities are regulated by sympathetic and parasympathetic nervous system. Evidence from experimental and clinical studies revealed significant role of sympathetic nervous system in bone homeostasis including osteoporosis. The bone remodelling isalso mediated by adrenergic neurons and its transmitters whichregulated by hypothalamus. The sympathetic signalling is also crucial for the osteoporosis development especially after menopause. In order to assess newer treatments for the disease, the potential role of sympathetic nervous system towards the development of osteoporosis is being investigated. The review outlines the evidences about significant role of sympathetic communication in bone remodelling with specific influence on osteoporosis.

4 March 2026
Verified
Book Chapter
Closed access
PDF file
FAFaraha Ahmed
Faraha Ahmed
DKDr. RAZIA KHANAM
Dr. RAZIA KHANAM
Neurological disorders primarily are an outcome of neurodegeneration, which is an age-associated progressive decline in neuronal activity. It causes cognitive dysfunction characterized by apoptosis and DNA damage. A considerable aging hallmark is cellular senescence that involves epigenetic, genetic and environmental factors. The proliferative cessation of the cell cycle is irreversible and is a well-regulated process that has favourable as well as deleterious effects in the body. Cellular senescence helps in removal of damaged proteins from the cells and decreases autophagic flux. There is substantial telomere shortening, mitochondrial dysfunction and inflammation. Senescent cells upregulate SCAP (senescent cell anti-apoptotic pathway) and display distinct SASP (senescence-associated secretory phenotype) that hinder their death regardless of damage to cell organelles and DNA. Aging hallmarks, specifically senescence, are crucial for neurological disorders including Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, epilepsy and amyotrophic lateral sclerosis. Therefore, targeting senescence therapeutically may offer improved and extended lifespan. The therapeutic targets include SASP and SCAP that led to the advancement in senotherapeutic agents that cause senescent cell death selectively. The drugs that target the arrest of specific senescent cells are recognised as senolytics, while the drugs that target SASP are known as senomorphics. Here we discuss the mechanism of cellular senescence in several neurological disorders in addition to the advancements in senotherapeutics that help to ameliorate neurological insufficiency.

4 March 2026
Verified
Book Chapter
Closed access
PDF file
SASyed Sufian Ahmad
Syed Sufian Ahmad
FAFaraha Ahmed
Faraha Ahmed
The skin is the largest but comprehensible organ that responds to several kinds of stimuli. It is an attractive organ to understand senolytic and senomorphic behavior of various agents to combat cellular senescence. Cellular senescence can occur due to apoptosis, replicative arrest, increased reactive oxygen species, metabolic and mitochondrial dysfunction or senescent-associated secretory factors. The traits of senescence can be detected with several factors like chronic inflammation, wound healing, oxidative stress or aging. These factors may cause delayed wound healing, wrinkles, skin sagging, decreased dermal collagen or fibroblast accumulation. Awareness regarding precise skin cells like melanocytes or fibroblasts will improve the understanding of skin-related degeneration and aging. Recent studies have defined the role of senescence in pathology and physiology of the skin. Dermatological research regarding impact of cellular senescence can improve the understanding of beneficial as well as deleterious effects of senotherapy on skin. This chapter presents the mechanisms and factors associated with skin cellular senescence and preclinical and clinical researchers that attempt to focus on agents that can benefit the pathophysiology of skin.